Login / Signup

High-dose intravenous immunoglobulin co-treatment prolongs time-to-treatment escalation in autoimmune bullous diseases: a monocentric retrospective cohort study.

M BertlichI BertlichN PlümacherE HadaschikA EnkJochen H O Hoffmann
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • high dose
  • multiple sclerosis
  • randomized controlled trial
  • clinical trial
  • combination therapy
  • stem cell transplantation
  • replacement therapy
  • drug induced
  • study protocol